Hershey Lead Independent Director Victor Crawford to not stand for re-election at May 2025 Annual Meeting

HERSHEY CO

Victor L. Crawford, Lead Independent Director, notified Hershey on March 7, 2025 of intention not to stand for re-election at May 6, 2025 Annual Meeting.
Crawford will continue as Lead Independent Director until the 2025 Annual Meeting.
Crawford stated his decision was not due to any disagreement with the Company on any matter relating to operations, policies or practices.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Victor L. Crawford

Lead Independent Director

HSY · HERSHEY CO

Effective: 2025-05-06
Filed: March 7, 2025, 6:59 PM ET

On March 7, 2025, Victor L. Crawford, Lead Independent Director of The Hershey Company (the “Company”), notified the Company of his intention not to stand for re-election as a director at the Company’s 2025 Annual Meeting of Stockholders, currently expected to be held on May 6, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Victor L. Crawford departed as Lead Independent Director at HERSHEY CO.

Action: notified intention not to stand for re-election
Role: Lead Independent Director

Exact text from the filing

On March 7, 2025, Victor L. Crawford, Lead Independent Director of The Hershey Company (the “Company”), notified the Company of his intention not to stand for re-election as a director at the Company’s 2025 Annual Meeting of Stockholders, currently expected to be held on May 6, 2025.

View on SEC.gov

HERSHEY CO filing history →

Source: SEC EDGAR

accession 0000047111-25-000022

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.